Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKD 11.62
(1.93%)
HKD 11.62
(1.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 144.5 Million CNY | 176.95% |
| 2022 | -187.79 Million CNY | -361.15% |
| 2021 | 71.9 Million CNY | 125.12% |
| 2020 | -286.24 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -15.75 Million CNY | -110.91% |
| 2024 Q2 | -15.75 Million CNY | 1318.05% |
| 2023 Q4 | 144.5 Million CNY | 44.38% |
| 2023 FY | 144.5 Million CNY | 176.95% |
| 2023 Q3 | 100.08 Million CNY | 252.4% |
| 2023 Q2 | -65.67 Million CNY | 49.3% |
| 2023 Q1 | -129.54 Million CNY | 31.02% |
| 2022 Q1 | 261.63 Million CNY | 263.85% |
| 2022 FY | -187.79 Million CNY | -361.15% |
| 2022 Q4 | -187.79 Million CNY | 26.72% |
| 2022 Q3 | -256.27 Million CNY | -191.73% |
| 2022 Q2 | 279.37 Million CNY | 6.78% |
| 2021 Q3 | -403.54 Million CNY | 0.0% |
| 2021 Q1 | 957.41 Million CNY | 0.0% |
| 2021 FY | 71.9 Million CNY | 125.12% |
| 2021 Q4 | 71.9 Million CNY | 117.82% |
| 2020 FY | -286.24 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | 289.223% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 97.256% |